Approvals/CIMA-AEMPS/SPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.4-5 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLE

Approved

STANDARD

SPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.4-5 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLE

Moderna Biotech Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 883be06b48a74e4f
Drug Cima Aemps Name: SPIKEVAX BIVALENTE ORIGINAL/OMICRON BA.4-5 (50 MICROGRAMOS/50 MICROGRAMOS)/ML DISPERSION INYECTABLE
Register Number: 1201507006
Holder Company Name: Moderna Biotech Spain S.L.
Marketing Company Name: Moderna Biotech Spain S.L.
Authorization Date: 2022-10-26
Dosage Form: DISPERSIÓN INYECTABLE
Dose: 50 MICROGRAMOS/50 MICROGRAMOS
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Moderna Biotech Spain S.L.

ELASOMERAN

0,05 mg

DAVESOMERAN

0,05 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 26, 2022

Approval ID

883be06b48a74e4f

Type

Standard